Research & development decreased 63.0%
Research & development changed -63.0% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development changed -63.0% from the comparable as-filed period.
SBC / revenue changed -190 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross debt changed -26.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Reported total debt changed -26.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash / debt changed +66561 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Noncurrent long-term debt changed -21.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating cash-flow margin changed -5946 basis points from the comparable as-filed period.
Receivables / revenue changed +750 basis points from the comparable as-filed period.
Trade receivables changed -10.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Operating income changed +3.6% from the comparable as-filed period.
Debt / revenue changed +55 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed +5.7% from the comparable as-filed period.
R&D / revenue changed -120 basis points from the comparable as-filed period.
Debt / assets changed +6 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Selling, general & administrative changed -0.7% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.